MOONLAKE IMMUNOTHERAPEUTICS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSat, 04 Apr 2026 08:38:36 +0200https://images.finanzen.net/images/finanzen_net_neu.gifMOONLAKE IMMUNOTHERAPEUTICS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netMoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTXMon, 15 Dec 2025 09:27:00 +0100https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15357961

LOS ANGELES, Dec. 15, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15357961DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025Thu, 11 Dec 2025 14:54:00 +0100https://www.finanzen.net/nachricht/aktien/deadline-next-week-berger-montague-advises-moonlake-immunotherapeutics-nasdaq-mltx-investors-to-contact-the-firm-before-december-15-2025-15352294

PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/deadline-next-week-berger-montague-advises-moonlake-immunotherapeutics-nasdaq-mltx-investors-to-contact-the-firm-before-december-15-2025-15352294MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTXThu, 11 Dec 2025 14:01:00 +0100https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15352082

LOS ANGELES, Dec. 11, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15352082MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmMon, 08 Dec 2025 09:23:00 +0100https://www.finanzen.net/nachricht/aktien/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-15341738

LOS ANGELES, Dec. 8, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-15341738MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTXMon, 08 Dec 2025 08:26:00 +0100https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15341595

LOS ANGELES, Dec. 8, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15341595MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmThu, 04 Dec 2025 13:51:00 +0100https://www.finanzen.net/nachricht/aktien/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-15335214

LOS ANGELES, Dec. 4, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-15335214MoonLake Immunotherapeutics (NASDAQ: MLTX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud LawsuitMon, 01 Dec 2025 14:36:00 +0100https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-nasdaq-mltx-deadline-approaching-berger-montague-advises-investors-of-deadline-in-securities-fraud-lawsuit-15324924

PHILADELPHIA, Dec. 1, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-nasdaq-mltx-deadline-approaching-berger-montague-advises-investors-of-deadline-in-securities-fraud-lawsuit-15324924MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmMon, 01 Dec 2025 10:28:00 +0100https://www.finanzen.net/nachricht/aktien/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-15324344

LOS ANGELES  , Dec. 1, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/mltx-investors-have-opportunity-to-lead-moonlake-immunotherapeutics-securities-fraud-lawsuit-with-the-schall-law-firm-15324344MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTXMon, 01 Dec 2025 10:25:00 +0100https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15324342

LOS ANGELES, Dec. 1, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-15324342INVESTOR ALERT: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025Mon, 24 Nov 2025 14:41:00 +0100https://www.finanzen.net/nachricht/aktien/investor-alert-berger-montague-advises-moonlake-immunotherapeutics-nasdaq-mltx-investors-to-inquire-about-a-securities-fraud-class-action-by-december-15-2025-15308724

PHILADELPHIA, Nov. 24, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/investor-alert-berger-montague-advises-moonlake-immunotherapeutics-nasdaq-mltx-investors-to-inquire-about-a-securities-fraud-class-action-by-december-15-2025-15308724